Lipocalin 2: A new mechanoresponding gene regulating bone homeostasis

Journal of Bone and Mineral Research

Volumn 30, Issue 2, 2015, Pages 357-368

  Rucci, Nadia ^a   Capulli, Mattia ^a   Piperni, Sara Gemini ^a   Cappariello, Alfredo ^b   Lau, Patrick ^c   Frings Meuthen, Petra ^c   Heer, Martina ^d   Teti, Anna ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c GERMAN AEROSPACE CENTER DLR   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

Adipokine; LCN2; Mechanical forces; Osteoblasts; Osteoclasts; Unloading

Indexed keywords

ADIPOCYTOKINE; ALKALINE PHOSPHATASE; BOTULINUM TOXIN A; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ALP; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LCN2 PROTEIN, MOUSE; LIPOCALIN; ONCOPROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BED REST; BIOMECHANICS; BONE; BONE MARROW DERIVED MONONUCLEAR CELL; BONE MARROW STROMA CELL; BONE MASS; CELL DIFFERENTIATION; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; FORCED SWIM TEST; GENE EXPRESSION; GRAVITY; HEK293 CELL LINE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMOBILIZATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; NORMAL HUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PARALYSIS; REGULATORY MECHANISM; SERUM; SODIUM INTAKE; TAIL SUSPENSION TEST; TREADMILL EXERCISE; UPREGULATION; ANIMAL; BLOOD; BONE DEVELOPMENT; C57BL MOUSE; CLINICAL TRIAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MECHANOTRANSDUCTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE;

ACUTE-PHASE PROTEINS; ADULT; ANIMALS; BED REST; BONE AND BONES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEK293 CELLS; HINDLIMB SUSPENSION; HOMEOSTASIS; HUMANS; LIPOCALINS; MALE; MECHANOTRANSDUCTION, CELLULAR; MICE, INBRED C57BL; ONCOGENE PROTEINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PARALYSIS; PHENOTYPE; PROTO-ONCOGENE PROTEINS;

EID: 84921753471     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2341     Document Type: Article

References (37)

1. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-32.
2. Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 1994;83:799-807.
3. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002;10:1033-43.
4. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;32:917-21.
5. Berger T, Togawa A, Duncan GS, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S.A. 2006;103:1834-9.
6. Wang Y, Lam KS, Kraegen EW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53:34-41.
7. Yan QW, Yang Q, Mody N, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes. 2007;56:2533-40.
8. Choi KM, Lee JS, Kim EJ, et al. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol. 2008;158:203-7.
9. Schmidt-Ott KM, Mori K, Kalandadze A, et al. Neutrophil gelatinase associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens. 2006;15:442-9.
10. Devireddy LR, Gazin C, Zhu X, Green MR. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell. 2005;123:1293-305.
11. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005;579:773-7.
12. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115:610-21.
13. Capulli M, Rufo A, Teti A, Rucci N. Global transcriptome analysis in mouse calvarial osteoblasts highlights sets of genes regulated by modeled microgravity and identifies a "mechanoresponsive osteoblast gene signature." J Cell Biochem. 2009;107:240-52.
14. Frings-Meuthen P, Buehlmeier J, Baecker N, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol. 2011;111:537-42.
15. Sakata T, Sakai A, Tsurukami H, et al. Trabecular bone turnover and bone marrow cell development in tail-suspended mice. J Bone Miner Res. 1999;14:1596-604.
16. Warner SE, Sanforda DA, Beckera BL, Bainb SD, Srinivasana S, Grossa TS. Botox induced muscle paralysis rapidly degrades bone. Bone. 2006;38:257-64.
17. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 1984;81:1189-92.
18. Rufo A, Del Fattore A, Capulli M, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res. 2011;26:1891-03.
19. Goes ATR, Souza LC, Filho CB, et al. Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine. Neuroscience. 2014;256:61-71.
20. Lorensen WE, Cline HE. Marching cubes: a high resolution 3D surface construction algorithm. Comput Graphics. 1987;21:163-9.
21. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25:1468-86.
22. Rucci N, Rufo A, Alamanou M, et al. The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis. J Cell Biol. 2009;187:669-83.
23. Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013;28:2-17.
24. Rucci N, Rufo A, Alamanou M, Teti A. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. J Cell Biochem. 2007;100:464-73.
25. Makris K, Rizos D, Kafkas N, Haliassos A. Neurophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med. 2012;50:1519-32.
26. Bolignano D, Donato V, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett. 2010;288:10-6.
27. Huang HL, Chu ST, Chen YH. Ovarian steroids regulate 24p3 expression in mouse uterus during the natural estrous cycle and the preimplantation period. J Endocrinol. 1999;162:11-9.
28. D'Anna R, Baviera G, Corrado F, Giordano D, Recupero S, Di Benedetto A. First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes. Diabet Med. 2009;26:1293-5.
29. Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A. 2008;105:14058-63.
30. Moniaux N, Chakraborty S, Yalniz M, et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer. 2008;98:1540-7.
31. Sun Y, Yokoi K, Li H, et al. NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res. 2011;17:4331-40.
32. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat. 2008;108:389-97.
33. Leng X, Lin H, Ding T, et al. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene. 2008;27:6110-9.
34. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276:37258-65.
35. Costa D, Biticchi R, Negrini S, et al. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone. Cytokine. 2010;51:47-52.
36. Costa D, Lazzarini E, Canciani B, et al. Altered bone development and turnover in transgenic mice over-expressing lipocalin-2 in bone. J Cell Physiol. 2013;228:2210-21.
37. Miravète M, Dissard R, Klein J, et al. Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. Am J Physiol Renal Physiol. 2012;302:F1409-7.